Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harvard Bioscience
(NQ:
HBIO
)
2.950
+0.090 (+3.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harvard Bioscience
< Previous
1
2
3
Next >
HBIO Stock Earnings: Harvard Bioscience Misses Revenue for Q2 2024
August 08, 2024
HBIO stock results show that Harvard Bioscience missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Harvard Bioscience Announces Second Quarter 2024 Financial Results
August 08, 2024
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
August 02, 2024
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Holley And 2 Other Stocks Under $5 Insiders Are Buying
June 17, 2024
Via
Benzinga
FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying
June 10, 2024
Via
Benzinga
A Preview Of Harvard Bioscience's Earnings
March 06, 2024
Via
Benzinga
Earnings Preview For Harvard Bioscience
November 06, 2023
Via
Benzinga
Preview: Harvard Bioscience's Earnings
August 07, 2023
Via
Benzinga
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
June 06, 2024
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
May 23, 2024
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
May 16, 2024
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024
May 07, 2024
HBIO stock results show that Harvard Bioscience met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Harvard Bioscience Announces First Quarter 2024 Financial Results
May 07, 2024
Strong gross margin performance and focus on efficiency to support ongoing investments in growth
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
April 29, 2024
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
April 09, 2024
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
March 11, 2024
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023
March 07, 2024
HBIO stock results show that Harvard Bioscience missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
March 07, 2024
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
March 06, 2024
Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
February 27, 2024
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
November 20, 2023
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
November 09, 2023
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience Announces Third Quarter 2023 Financial Results
November 07, 2023
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
November 06, 2023
Innovative solutions for academic, CRO, pharma and biotech customers
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
October 30, 2023
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
September 18, 2023
From
Harvard Bioscience, Inc.; Etisense
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 30, 2023
Via
Benzinga
Harvard Bioscience Announces Second Quarter 2023 Financial Results
August 08, 2023
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
August 03, 2023
From
Harvard Bioscience, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.